A Phase 3b/4 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Verify the Clinical Benefit of Aducanumab (BIIB037) in Participants with Alzheimer’s Disease (ENVISION Study)
A Phase 2b, Randomized, Controlled, Open-label Study to Evaluate the Immune Response and Safety of the RSVPreF3 OA Investigational Vaccine in Adults (≥50 Years of Age) When Administered to Lung and Renal Transplant Recipients Comparing 1 Versus 2 Doses and Compared to Healthy Controls (≥50 Years of Age) Receiving 1 Dose
A Randomized, Partially Masked, Controlled, Phase 3 Clinical Study to Evaluate the Efficacy and Safety of RGX-314 Gene Therapy in Participants with nAMD
Age-related macular degeneration (AMD) is the leading cause of vision loss among older adults, affecting approximately 2.5 million Canadians. The condition progressively affects the macula, a part of the retina that plays a crucial role in our vision precision. With time, AMD can result in blurred vision or a blind spot in the centre of a person's field of vision.
A rapid response line for medical professionals with workplace-related health and safety questions and concerns has apparently been a long time coming, according to Vancouver Coastal Health Research Institute researcher Dr. Annalee Yassi. Together with other health care workers and researchers, Yassi led the medical Practitioner Occupational Safety and Health (mPOSH) initiative, which provides prompt dedicated support and guidance to medical professionals.
